Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Felipe G, Sandoval"'
Autor:
Sérgio Luís Gomes Antunes, A. B. R. Ferreira, E.J. Shannon, Felipe G. Sandoval, Thiago Gomes de Toledo-Pinto, Patrícia Sammarco Rosa, Lucia Elena Alvarado-Arnez, Diana L. Williams, Leonardo Ribeiro Batista-Silva, Marcelo Ribeiro-Alves, Flávio Alves Lara, Alejandra N. Martinez, Luciana Silva Rodrigues, Bruno Jorge de Andrade Silva, Euzenir Nunes Sarno, Milton Ozório Moraes, Maria Cristina Vidal Pessolani, Roberta Olmo Pinheiro, Robertha Mariana Rodrigues Lemes
Publikováno v:
Journal of Infectious Diseases. 214:311-320
Cytosolic detection of nucleic acids elicits a type I interferon (IFN) response and plays a critical role in host defense against intracellular pathogens. Herein, a global gene expression profile of Mycobacterium leprae-infected primary human Schwann
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e3c674d2b6cdad9403f151b5b18e4ab
https://doi.org/10.1093/infdis/jiw144
https://doi.org/10.1093/infdis/jiw144
Publikováno v:
Leprosy Review. 79:311-314
Summary Objective The immune-mediated events that precipitate erythema nodosum leprosum (ENL) are not well understood. One component may be the complexing of antibody with antigens released from infected macrophages, the activation of complement and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f0acfae3b5840205d2af2f1506930ba7
https://doi.org/10.47276/lr.79.3.311
https://doi.org/10.47276/lr.79.3.311
Publikováno v:
Immunopharmacology and Immunotoxicology. 30:447-457
Thalidomide is used to treat erythema nodosum leprosum (ENL). The events that precipitate this inflammatory reaction, which may occur in multibacillary leprosy patients, and the mechanism by which thalidomide arrest ENL, are not known. Thalidomide's
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3549e44c130183c6133019ea71325d78
https://doi.org/10.1080/08923970802135161
https://doi.org/10.1080/08923970802135161
Publikováno v:
Translational Research. 150:275-280
An early rationale for using thalidomide to treat erythema nodosum leprosum had been based on some reports that it suppresses tumor necrosis factor-alpha (TNF-alpha). However, in vivo and in vitro studies have yielded variable results, having shown t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aeaa1d6cf051b9d00b2ea068d9892ac5
https://doi.org/10.1016/j.trsl.2007.05.003
https://doi.org/10.1016/j.trsl.2007.05.003
Autor:
Michael T. Kearney, Edward J. Shannon, Abolghasem Baghian, Anna Israyelyan, Felipe G. Sandoval
Publikováno v:
Immunopharmacology and immunotoxicology. 34(3)
Thalidomide (Thal) can suppress the growth of established, as well as explanted tumors in mice. We wanted to determine if it could suppress the ability of tumor cells to assemble and establish a primary tumor at the injection site. Using the mouse 4T
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::69d192a3289d3087f30fbb917893a8fd
https://pubmed.ncbi.nlm.nih.gov/21942927
https://pubmed.ncbi.nlm.nih.gov/21942927
Publikováno v:
Leprosy review. 79(3)
The immune-mediated events that precipitate erythema nodosum leprosum (ENL) are not well understood. One component may be the complexing of antibody with antigens released from infected macrophages, the activation of complement and the subsequent loc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c5756a2a1b7616f37743c3b8f6bdac01
https://pubmed.ncbi.nlm.nih.gov/19009980
https://pubmed.ncbi.nlm.nih.gov/19009980
Autor:
Naoko Robbins, Stephen Keas, Diana L. Williams, Thomas P. Gillis, David M. Scollard, Felipe G. Sandoval, Cheryl Lewis
Publikováno v:
Clinical Infectious Diseases. 58:72-73
Molecular drug susceptibility testing was performed on 39 US patients with leprosy. Of these, 2 had dapsone-resistant Mycobacterium leprae and 1 of these patients also had rifampin-resistant M. leprae. Even though antileprosy drug resistance occurs i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99576c4bb5a31b38a41adcdecee775b0
https://doi.org/10.1093/cid/cit628
https://doi.org/10.1093/cid/cit628
Autor:
Felipe G. Sandoval, Edward J. Shannon
Publikováno v:
International immunopharmacology. 2(8)
Thalidomide is a drug that can enhance mitogen- and antigen-stimulated cells' ability to synthesize IL-2. To assess if thalidomide could concomitantly enhance the synthesis of IFN-gamma and incorporation of [H3]-thymidine, peripheral blood mononuclea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f818fb4f11d6de3c1abe98c5bed3b7b
https://pubmed.ncbi.nlm.nih.gov/12349951
https://pubmed.ncbi.nlm.nih.gov/12349951